A detailed history of United Advisor Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, United Advisor Group, LLC holds 2,918 shares of ABBV stock, worth $572,132. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,918
Previous 4,472 34.75%
Holding current value
$572,132
Previous $794,000 23.05%
% of portfolio
0.13%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

SELL
$169.2 - $216.66 $262,936 - $336,689
-1,554 Reduced 34.75%
2,918 $611,000
Q4 2024

Feb 24, 2025

BUY
$164.99 - $203.87 $14,849 - $18,348
90 Added 2.05%
4,472 $794,000
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $339,968 - $413,609
2,075 Added 89.94%
4,382 $865,000
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $357,100 - $417,013
2,307 New
2,307 $395,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $347B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track United Advisor Group, LLC Portfolio

Follow United Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Advisor Group, LLC with notifications on news.